Abstract
Switching from cigarette smoking to electronic nicotine delivery systems (ENDS) reduces exposure to toxic substances. Yet, many smokers believe ENDS are at least as harmful as smoking, making them less likely to switch from cigarettes to ENDS. Effectively communicating reduced-exposure information is critical, but such messages must be properly understood. This online study evaluated comprehension of a factual message indicating that smokers who switch completely away from smoking to JUUL-brand ENDS can reduce their exposure to harmful chemicals in cigarette smoke. Participants were 12,557 adults 18+ (smokers, dual users, former and never users of tobacco) randomized to see the reduced-exposure message or to a Control condition. After exposure to the message, the majority of smokers (89%) understood the need to switch completely from cigarettes to JUUL to achieve reduced exposure. Most smokers and non-users (>75%) did not misperceive JUUL as completely eliminating exposure to harmful chemicals, and >85% understood that using JUUL has risk. Exposure to the message improved understanding of the intended audience for JUUL. Individuals with limited health literacy showed modestly lower comprehension, regardless of condition. Ensuring adequate comprehension of messages about reduced exposure from ENDS is important to ensuring that such messaging can benefit public health.
Reference34 articles.
1. McNeill A, Simonavičius E, Brose LS et al. Nicotine vaping in England: an evidence update including health risks and perceptions, September 2022. A report commissioned by the Office for Health Improvement and Disparities. London: Office for Health Improvement and Disparities. 2022.
2. National Academies of Sciences Engineering and Medicine. Public health consequences of e-cigarettes. Washington, DC: The National Academies Press,2018.
3. Talih S, Salman R, El-Hage R et al. Characteristics and toxicant emissions of JUUL electronic cigarettes Tob Control 2019;28:678-680. First published on 2019/02/13, 10.1136/tobaccocontrol-2018-054616.
4. Edmiston JS, Webb KM, Wang J et al. Biomarkers of Exposure and Biomarkers of Potential Harm in Adult Smokers Who Switch to e-Vapor Products Relative to Cigarette Smoking in a 24-week, Randomized, Clinical Trial Nicotine Tob Res 2022;24:1047-1054. First published on 2022/02/09, 10.1093/ntr/ntac029.
5. Kanobe MN, Jones BA, Nelson P et al. Part three: a randomized study to assess biomarker changes in cigarette smokers switched to Vuse Solo or Abstinence Sci Rep 2022;12:20658. First published on 2022/12/01, 10.1038/s41598-022-25054-z.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献